MEDICURE INC. Files November 2024 6-K Report
Ticker: MCUJF · Form: 6-K · Filed: Nov 26, 2024 · CIK: 1133519
| Field | Detail |
|---|---|
| Company | Medicure Inc (MCUJF) |
| Form Type | 6-K |
| Filed Date | Nov 26, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
Medicare Inc. filed its monthly 6-K, just routine paperwork for Canadian companies.
AI Summary
On November 26, 2024, MEDICURE INC. filed a Form 6-K with the SEC, reporting information for the month of November 2024. The company, based in Winnipeg, Canada, is a foreign private issuer and files its annual reports under Form 20-F. This filing does not appear to contain specific financial transactions or material events beyond its routine reporting status.
Why It Matters
This filing indicates Medicare Inc. is fulfilling its regular reporting obligations as a foreign private issuer with the SEC, providing transparency to investors.
Risk Assessment
Risk Level: low — This filing is a routine report for a foreign private issuer and does not disclose any new material risks or events.
Key Players & Entities
- MEDICURE INC. (company) — Registrant
- Winnipeg, MB Canada (location) — Company Headquarters
- 20241126 (date) — Filing Date
- November 2024 (date) — Reporting Period
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K filing is used by foreign private issuers to report information that they have made or are required to make public in their home country, file with a stock exchange, or distribute to their security holders.
Which annual report form does MEDICURE INC. use?
MEDICURE INC. indicates it files its annual reports under cover of Form 20-F.
Where is MEDICURE INC. headquartered?
MEDICURE INC. is headquartered at 2-1250 Waverley Street, Winnipeg, MB Canada R3T 6C6.
What is the Commission File Number for MEDICURE INC.?
The Commission File Number for MEDICURE INC. is 001-31995.
Does this filing indicate MEDICURE INC. is submitting information under Rule 12g3-2(b)?
No, the filing explicitly states 'No' next to the checkbox for whether the registrant is furnishing information to the Commission pursuant to Rule 12g3-2(b).
Filing Stats: 253 words · 1 min read · ~1 pages · Grade level 9.7 · Accepted 2024-11-26 09:32:41
Filing Documents
- med_6k.htm (6-K) — 11KB
- med_ex991.htm (EX-99.1) — 542KB
- med_ex992.htm (EX-99.2) — 466KB
- med_ex993.htm (EX-99.3) — 9KB
- med_ex994.htm (EX-99.4) — 9KB
- med_ex991img5.jpg (GRAPHIC) — 3KB
- med_ex991img3.jpg (GRAPHIC) — 3KB
- med_ex991img2.jpg (GRAPHIC) — 5KB
- med_ex992img3.jpg (GRAPHIC) — 3KB
- med_ex992img2.jpg (GRAPHIC) — 2KB
- med_ex992img1.jpg (GRAPHIC) — 5KB
- 0001654954-24-014900.txt ( ) — 1071KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Medicure Inc. (Registrant) Date: November 25, 2024 By: /s/ Dr. Albert D. Friesen Dr. Albert D. Friesen Title: CEO 3